In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.

Intra-arterial thrombolysis via urokinase following reperfusion by endovascular thrombectomy for stroke does not affect survival without disability.

Researchers linked higher weight loss after initiating antiobesity meds to lower risk for revision of hip and knee replacement.

Researchers found an association between higher adherence to the Mediterranean diet and a modest reduction in the risk for obesity-related cancers.

Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.

The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with aspirin, to: Reduce the risk of major cardiovascular ...

The FDA has granted Priority Review to the BLA for deramiocel (CAP-1002) for the treatment of Duchenne muscular dystrophy cardiomyopathy.

GLP-1RAs were not associated with an increased risk for thyroid cancer relative to DPP-4 inhibitor use among an international cohort.

In recent years, the rate of cardiovascular mortality following high-risk myocardial infarction has significantly declined.

A scientific statement regarding clinical considerations for athletes with cardiovascular abnormalities has been published by the AHA and ACC.

Wearable equipment-based telemedical management via multiparameter monitoring can help improve management in older patients with coronary heart disease.

Many patients with advanced cancer receive potentially aggressive care in the last month of life at the expense of supportive care.